Histone acetylation: a key determinant of acquired cisplatin resistance in cancer.

Clin Epigenetics · 2024 · PMC10765630 · PMID 38172984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Moreover, in the cisplatin-treated group, these marks showed an increasing trend correlating with in vitro data.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.